Literature DB >> 19808716

Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study.

Ulf G Bronas1, Alan T Hirsch, Timothy Murphy, Dalynn Badenhop, Tracie C Collins, Jonathan K Ehrman, Abby G Ershow, Beth Lewis, Diane J Treat-Jacobson, M Eileen Walsh, Niki Oldenburg, Judith G Regensteiner.   

Abstract

The CLaudication: Exercise Vs Endoluminal Revascularization (CLEVER) study is the first randomized, controlled, clinical, multicenter trial that is evaluating a supervised exercise program compared with revascularization procedures to treat claudication. In this report, the methods and dissemination techniques of the supervised exercise training intervention are described. A total of 217 participants are being recruited and randomized to one of three arms: (1) optimal medical care; (2) aortoiliac revascularization with stent; or (3) supervised exercise training. Of the enrolled patients, 84 will receive supervised exercise therapy. Supervised exercise will be administered according to a protocol designed by a central CLEVER exercise training committee based on validated methods previously used in single center randomized control trials. The protocol will be implemented at each site by an exercise committee member using training methods developed and standardized by the exercise training committee. The exercise training committee reviews progress and compliance with the protocol of each participant weekly. In conclusion, a multicenter approach to disseminate the supervised exercise training technique and to evaluate its efficacy, safety and cost-effectiveness for patients with claudication due to peripheral arterial disease (PAD) is being evaluated for the first time in CLEVER. The CLEVER study will further establish the role of supervised exercise training in the treatment of claudication resulting from PAD and provide standardized methods for use of supervised exercise training in future PAD clinical trials as well as in clinical practice.

Entities:  

Mesh:

Year:  2009        PMID: 19808716     DOI: 10.1177/1358863X09102295

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  14 in total

Review 1.  Peripheral artery disease. Part 2: medical and endovascular treatment.

Authors:  Mitchell D Weinberg; Joe F Lau; Kenneth Rosenfield; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-06-14       Impact factor: 32.419

2.  Peripheral artery disease: current insight into the disease and its diagnosis and management.

Authors:  Jeffrey W Olin; Brett A Sealove
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

Review 3.  Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits.

Authors:  Naomi M Hamburg; Gary J Balady
Journal:  Circulation       Date:  2011-01-04       Impact factor: 29.690

4.  Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication.

Authors:  Timothy P Murphy; Matthew R Reynolds; David J Cohen; Judith G Regensteiner; Joseph M Massaro; Donald E Cutlip; Emile R Mohler; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Suzanne Goldberg; Alan T Hirsch
Journal:  J Vasc Interv Radiol       Date:  2013-07-29       Impact factor: 3.464

5.  Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study.

Authors:  Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Suzanne Goldberg; Michael R Jaff; Michael W Steffes; Anthony J Comerota; Jonathan Ehrman; Diane Treat-Jacobson; M Eileen Walsh; Tracie Collins; Dalynn T Badenhop; Ulf Bronas; Alan T Hirsch
Journal:  Circulation       Date:  2011-11-16       Impact factor: 29.690

6.  Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study.

Authors:  Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Michael R Jaff; Anthony J Comerota; Michael W Steffes; Ingrid H Abrahamsen; Suzanne Goldberg; Alan T Hirsch
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094

7.  Translation of an evidence-based therapeutic exercise program for patients with peripheral artery disease.

Authors:  Dereck L Salisbury; Mary O Whipple; Marsha Burt; Rebecca J L Brown; Alan Hirsch; Christopher Foley; Diane Treat-Jacobson
Journal:  J Vasc Nurs       Date:  2017-11-01

8.  Effects of exercise training on calf muscle oxygen extraction and blood flow in patients with peripheral artery disease.

Authors:  Wesley B Baker; Zhe Li; Steven S Schenkel; Malavika Chandra; David R Busch; Erin K Englund; Kathryn H Schmitz; Arjun G Yodh; Thomas F Floyd; Emile R Mohler
Journal:  J Appl Physiol (1985)       Date:  2017-10-05

9.  Exercise Training and Cognitive Function in Kidney Disease: Protocol for a Pilot Randomized Controlled Trial.

Authors:  Ulf G Bronas; Mary Hannan; James P Lash; Olu Ajilore; Xiaohong Joe Zhou; Melissa Lamar
Journal:  Nurs Res       Date:  2022 Jan-Feb 01       Impact factor: 2.381

Review 10.  Exercise for intermittent claudication.

Authors:  Risha Lane; Amy Harwood; Lorna Watson; Gillian C Leng
Journal:  Cochrane Database Syst Rev       Date:  2017-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.